What is the treatment approach for a Staphylococcus (Staph) epidermidis urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Staphylococcus epidermidis Urinary Tract Infection

For Staphylococcus epidermidis UTI, obtain urine culture to confirm true infection (≥50,000 CFUs/mL in pure growth), then treat with vancomycin for methicillin-resistant strains or penicillinase-resistant penicillins for susceptible strains, with treatment duration of 7-14 days depending on symptom resolution. 1

Diagnosis Confirmation

Before initiating treatment, it's crucial to distinguish between colonization and true infection:

  • Obtain a urine specimen for culture prior to starting antimicrobial therapy
  • A pure growth of ≥50,000 CFUs/mL of S. epidermidis suggests true infection rather than contamination 1
  • Consider patient symptoms and risk factors (indwelling catheters, nephrolithiasis, recent instrumentation) 2, 3

Risk Factors for S. epidermidis UTI

S. epidermidis is not a common uropathogen but can cause UTIs in specific situations:

  • Indwelling urinary catheters or other devices 4, 5
  • Recent urinary tract instrumentation 3
  • Nephrolithiasis 2
  • Immunocompromised status 4
  • Anatomical abnormalities (especially in children) 3

Treatment Approach

First-line Treatment Options

For methicillin-resistant S. epidermidis (common in nosocomial infections):

  • Vancomycin is the drug of choice 4
  • Consider combination therapy with rifampin or gentamicin for serious infections 4

For methicillin-susceptible S. epidermidis:

  • Penicillinase-resistant penicillins
  • Cephalosporins (if susceptible) 4

Alternative Options (based on susceptibility testing)

  • Doxycycline (69% of isolates susceptible in prosthetic joint infections) 6
  • Linezolid (high susceptibility rates) 6
  • Nitrofurantoin 100mg twice daily for uncomplicated cases 1
  • Trimethoprim-sulfamethoxazole 160/800mg twice daily if susceptible 1

Treatment Duration

  • 7 days for patients with prompt resolution of symptoms 1
  • 10-14 days for those with delayed response 1
  • For complicated UTIs (presence of risk factors, bacteremia), extend treatment to 10-14 days 1

Catheter Management

If a urinary catheter is present:

  • If the catheter has been in place for ≥2 weeks, replace it to hasten symptom resolution 1
  • Obtain urine culture specimens from freshly placed catheters 1
  • Remove the catheter completely as soon as possible if no longer needed 1

Monitoring and Follow-up

  • Monitor clinical response within 72 hours of initiating therapy 1
  • Consider extending treatment duration, performing urologic evaluation, or adjusting antimicrobial regimen if no improvement occurs 1
  • For patients with bacteremia, follow blood cultures to confirm clearance 2, 5

Special Considerations

  • S. epidermidis can cause serious infections including bacteremia and septic shock, especially in debilitated patients 5
  • Methicillin resistance is common in nosocomial S. epidermidis infections 4
  • Standard susceptibility testing methods may not reliably detect methicillin resistance in S. epidermidis 4
  • In patients with nephrolithiasis and S. epidermidis UTI, consider ureteral stenting in addition to antibiotic therapy 2

Common Pitfalls

  • Dismissing S. epidermidis as a contaminant without considering clinical context 3
  • Failing to use reliable methods for detecting methicillin resistance 4
  • Not removing or replacing indwelling catheters when treating the infection 1
  • Inadequate treatment duration for complicated infections 1
  • Not considering underlying anatomical abnormalities, especially in children 3

References

Guideline

Urinary Tract Infection Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Two cases of pyelonephritis with bacteremia by Staphylococcus epidermidis in male patients with nephrolithiasis: Case reports and a literature review.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.